Healthy Participants

The Strong Gut Study Part 2

3 night stay + 1 night + 1 night, 11 follow ups

Help Test a New Potential drug for the Treatment of IBD

This clinical study is evaluating a potential new drug to treat IBD. IBD is a term used to describe conditions that cause abdominal pain and diarrhoea, among other symptoms.

The study drug is designed to reduce the inflammatory response that causes IBD symptoms. 

The study is a randomised, double-blind, placebo-controlled trial. The purpose of this study is to assess the safety and tolerability of a single dose in healthy men and women with a BMI of 18–35.

Schedule

Cohort 4.1

Check In

Nov 15th

Check Out

Nov 18th

Nov 23rd

-

Check In

Dec 01st

Check Out

Dec 02nd

Dec 07th

-

Check In

Dec 14th

Check Out

Dec 15th

Dec 21st, 28th, Jan 04th, 11th, 25th, Feb 08th, Mar 08th, Apr 05th, May 03rd

Cohort 4.2

Check In

Nov 16th

Check Out

Nov 19th

Nov 24th

-

Check In

Dec 02nd

Check Out

Dec 03rd

Dec 08th

-

Check In

Dec 15th

Check Out

Dec 16th

Dec 22nd, 29th, Jan 05th, 12th, 26th, Feb 09th, Mar 09th, Apr 06th, May 04th

To Qualify, You Must

New healthy volunteer study coming soon.

Spots are limited. Find out if you qualify today!